A detailed history of Degroof Petercam Asset Management transactions in United Therapeutics Corp stock. As of the latest transaction made, Degroof Petercam Asset Management holds 11,200 shares of UTHR stock, worth $4.09 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
11,200
Previous 25,200 55.56%
Holding current value
$4.09 Million
Previous $5.54 Billion 53.57%
% of portfolio
0.03%
Previous 0.07%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$210.76 - $249.51 $2.95 Million - $3.49 Million
-14,000 Reduced 55.56%
11,200 $2.57 Billion
Q4 2023

Feb 14, 2024

BUY
$214.88 - $256.94 $5.41 Million - $6.47 Million
25,200 New
25,200 $5.54 Billion

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.6B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Degroof Petercam Asset Management Portfolio

Follow Degroof Petercam Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Degroof Petercam Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Degroof Petercam Asset Management with notifications on news.